Arnoud van 't Hof

Professor

Prof. Arnoud van ‘t Hof is Interventional Cardiologist and head of the department of Interventional Cardiology in Maastricht University Medical Center and Zuyderland Medical Center in Heerlen, the Netherlands. He has a long-standing research history in cardiovascular medicine, particularly in the field of primary angioplasty and acute coronary syndromes, with special interest in pre-hospital diagnosis and triage in the ambulance. He has been (co-) chairing international multi-center clinical trials in this field. He is a board member of the Acute Cardiac Care Association (ACCA) and editorial board member of the European Heart Journal Acute Cardiovascular Care and the Netherlands Heart Journal. He chaired the board of directors of the National Cardiovascular Data Registry (NCDR, now Nederlandse Hart Registratie (NHR) with specific interest for value based healthcare (VBHC) and data science. He recently joined the European Association of Preventive Cardiology (EAPC) with research on Cardiac Rehabilitation, Cardiovascular Prevention and Sports Medicine.

Prof. Arnoud van ‘t Hof has authored over 350 publications in peer-reviewed cardiovascular journals. He is an elected fellow of the ESC.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht

  • 2026
    • Januzzi, J. L., Gibson, C. M., Chi, G., Coller, B. S., Granger, C. B., Montalescot, G., Rikken, S. A. O. F., Verburg, A., Berg, J. M. T., & van 't Hof, A. W. J. (2026). The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI. American Heart Journal, 301, Article 107513. https://doi.org/10.1016/j.ahj.2026.107513
    • Janssen, S., Luijkx, J. J. P., Swinnen, W., Vriesendorp, P., ten Berg, J. M., van ‘t Hof, A. W. J., Rasoul, S., & SLIM-2 study group (2026). Direct oral anticoagulation interruption vs continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: Design and rationale of the South Limburg Myocardial Infarction Study Group Trial 2 (SLIM-2). American Heart Journal, 299, Article 107462. https://doi.org/10.1016/j.ahj.2026.107462
    • Roefs, M. M., Amoroso, G., Camaro, C., Daeter, E. J., Grundeken, M. J., van 't Hof, A. W. J., de Lind van Wijngaarden, R. A. F., Lipsic, E., Meuwissen, M., van der Harst, P., van Veghel, D., & Netherlands Heart Registration (2026). Cardiology in numbers: coronary artery disease in the Netherlands. Netherlands Heart Journal, 34(7-8), 283-284. https://doi.org/10.1007/s12471-026-02058-2
    • Peeters, D. A. M., Woelders, E. C. I., Janssen, S., Azzahhafi, J., Yin, D. R. P. P. C. P., van den Broek, W. W. A., Winkler, P. J. C., van de Pol, Q. Y. F., Cetinyurek-Yavuz, A., Damman, P., Luijkx, J. J. P., Remkes, W. S., van't Hof, A. W. J., ten Berg, J. M., & van Geuns, R. J. M. (2026). Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients. IJC Heart and Vasculature, 65, Article 101961. https://doi.org/10.1016/j.ijcha.2026.101961
    • De Koning, I. A., Heutinck, J. M., Buckley, B. J. R., Dibben, G. O., Campo, G., Hautala, A. J., Snoek, J. A., Maddison, R., Santaularia, N., Lear, S. A., Houle, J., Lip, G. Y. H., Van Geuns, R. J. M., Vromen, T., Kemps, H. M. C., Taylor, R. S., Stens, N. A., Thijssen, D. H. J., Hughes, A. D., ... CaReMATCH collaborators (2026). Exercise-based cardiac rehabilitation for patients with angina pectoris - a CaReMATCH individual participant data meta-analysis. American Journal of Preventive Cardiology, 28, Article 101535. https://doi.org/10.1016/j.ajpc.2026.101535
    • van Susante, L., van Mierlo, R., Scheenstra, B., van't Hof, A., & Nia, P. S. (2026). Monitoring cardiac symptoms during teleprehabilitation prior to coronary artery bypass grafting: a digital cardiac counselling trial subanalysis. European Heart Journal - Digital Health, 7(5), Article ztag076. https://doi.org/10.1093/ehjdh/ztag076
    • van Wely, C., Oosterveld, R. J., Zonnebeld, N., Yazar, O., van 't Hof, A. W. J., & Bouwman, L. H. (2026). Interobserver and Intraobserver Variability in Crural Angiography. Journal of Endovascular Therapy, 33(3), 1458-1466. https://doi.org/10.1177/15266028251315029
    • Heuts, S., Pustjens, T. F. S., Lux, Á., Gabrio, A., van 't Hof, A. W. J., Rasoul, S., & SLIM trial investigators (2026). Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: a Bayesian re-analysis of the SLIM trial. American heart journal, 296, Article 107369. https://doi.org/10.1016/j.ahj.2026.107369
    • van Mierlo, R. F. R., Heijkens-Verberkt, F. W. W., Houben, V. J. G., Rikken, S. A. O. F., Kalendralis, P., Hochstenbach, L. M. J., Lozano-Torres, J., & van t Hof, A. W. J. (2026). Patient characteristics of non-participants and reasons for non-participation in cardiac (tele)rehabilitation-a prospective analysis. Frontiers in Rehabilitation Sciences, 7, Article 1844025. https://doi.org/10.3389/fresc.2026.1844025
    • Bova, R., Bastings, J., Betti, M., Snik, C., Heuts, S., Segers, P., Winkler, P. J. C., Vriesendorp, P. A., Bidar, E., ten Berg, J. M., Lux, A., van't Hof, A. W. J., & COMMIT LAD Investigators (2026). Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment Strategies for Patients With Significant Left Anterior Descending Artery Disease (COMMIT-LAD). Journal of Cardiovascular Pharmacology, 87(5), 357-363. https://doi.org/10.1097/FJC.0000000000001799